Holen Sie sich die Stockscreener-App
8.905
12.01%
0.955
Handel nachbörslich:
9.00
0.095
+1.07%
Schlusskurs vom Vortag:
$7.95
Offen:
$7.95
24-Stunden-Volumen:
119.53K
Relative Volume:
1.00
Marktkapitalisierung:
$8.34M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0916
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
-5.57%
1M Leistung:
-63.35%
6M Leistung:
-82.94%
1J Leistung:
-99.52%
1-Tages-Spanne:
$7.66
$9.14
1-Wochen-Bereich:
$7.66
$9.7601
52-Wochen-Spanne:
$7.66
$1,868.40
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Firmenname
Aptevo Therapeutics Inc
Sektor
Branche
Telefon
206-838-0500
Adresse
2401 4TH AVE., SEATTLE, WA
Vergleichen Sie APVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
8.905 | 7.44M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-11-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-10-05 | Fortgesetzt | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten
Quarterly Recap: Will Aptevo Therapeutics Inc stock continue upward momentumAnalyst Downgrade & Growth Oriented Trade Recommendations - moha.gov.vn
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aptevo Therapeutics announces 1-for-18 reverse stock split - MSN
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis By Investing.com - Investing.com Australia
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis - Investing.com Australia
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split - TipRanks
Aptevo Therapeutics To Implement 1-for-18 Reverse Stock Split - Nasdaq
Aptevo Therapeutics Inc. (APVO) Stock: Plummets 36% Ahead of 1-for-18 Reverse Split - parameter.io
Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval - Asianet Newsable
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Aptevo Therapeutics (APVO) Announces 1-for-18 Reverse Stock Spli - GuruFocus
Aptevo Therapeutics stock slumps to all-time low on reverse split approval - MSN
What's Going On With Aptevo Therapeutics Stock Today?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga
Aptevo Therapeutics to implement 1-for-18 reverse stock split By Investing.com - Investing.com Nigeria
US Stocks Mixed; Biohaven Shares Fall - Benzinga
Aptevo Therapeutics to implement 1-for-18 reverse stock split - Investing.com
Aptevo Therapeutics stock tumbles after announcing 1-for-18 reverse split - Investing.com
Aptevo Therapeutics to Conduct 1-for-18 Reverse Stock Split; Shares Fall Pre-Bell - MarketScreener
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split - standard-journal.com
Aptevo Therapeutics Inc announces 1-for-18 reverse stock split - marketscreener.com
Biotech firm turns every 18 shares into 1 in year-end stock move - Stock Titan
Sector Update: Health Care - MarketScreener
Total debt per share of Aptevo Therapeutics, Inc. – MUN:AP81 - TradingView — Track All Markets
How analysts rate Aptevo Therapeutics Inc. stock todayMarket Trend Summary & AI Powered Market Entry Ideas - Улправда
Aptevo Therapeutics Earnings Notes - Trefis
Fed Watch: Is Aptevo Therapeutics Inc. stock a buy for dividend growthBull Run & Weekly Watchlist for Hot Stocks - DonanımHaber
Is Aptevo Therapeutics Inc. stock trading at a premium valuation2025 Market Sentiment & Technical Pattern Based Signals - Улправда
Will Aptevo Therapeutics Inc. stock attract ESG investorsJuly 2025 Setups & Community Verified Watchlist Alerts - Улправда
Aug Outlook: Can Aptevo Therapeutics Inc. (AP81) stock withstand sector downturns2025 Top Gainers & Capital Efficient Trading Techniques - Улправда
Will Aptevo Therapeutics Inc. stock outperform Dow Jones indexBond Market & Weekly Breakout Opportunity Watchlist - Улправда
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study - MSN
Aptevo Therapeutics Inc AP81 Stock Analysis and ForecastHealthcare Stock Analysis & High Return Trading Strategies - earlytimes.in
Volume Report: Is Aptevo Therapeutics Inc stock supported by strong fundamentalsShare Buyback & Accurate Intraday Trading Signals - moha.gov.vn
Omniab Plans to Launch Its New Omniultra? Transgenic Chicken Platform in December 2025 At the Antibody Engineering & Therapeutics Conference - marketscreener.com
Prepare Yourself for Liftoff: Aptevo Therapeutics Inc (APVO) - setenews.com
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy - ts2.tech
Aptevo Therapeutics Announces Promising RAINIER Trial Results - TipRanks
Aptevo’s AML therapy shows strong safety profile in phase 1b/2 trial - Investing.com
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025 - ACCESS Newswire
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):